Erratum regarding missing Declaration of Competing Interest statements in previously published articles

Declaration of Competing Interest statements were not included in published version of the following articles that appeared in previous issues of Diabetes & Metabolic Syndrome: Clinical Research & Reviews. Hence, the authors of the below articles were contacted after publication to request a Declaration of Interest statement:

• 1.“Clinical considerations for patients with diabetes in times of COVID-19 epidemic” [Diabetes & Metabolic Syndrome: Clinical Research & Reviews, 2020; 14 (3): 211–212] https://doi.org/10.1016/j.dsx.2020.03.002
• 2.2. “Social isolation during Covid-19: Boon or bane to diabetes management” [Diabetes & Metabolic Syndrome: Clinical Research & Reviews, 2020; 14 (4): 567–568]
• 3.https://doi.org/10.1016/j.dsx.2020.04.046
• 4.3. “Blood glucose levels should be considered as a new vital sign indicative of prognosis during hospitalization” [Diabetes & Metabolic Syndrome: Clinical Research & Reviews, 2020; 15 (1): 221–227]
• 5.https://doi.org/10.1016/j.dsx.2020.12.032
• 6.“Contentious Issues and Evolving Concepts in the Clinical Presentation and Management of Patients with COVID-19 Infection with Reference to Use of Therapeutic and Other Drugs used in Co-morbid Diseases (Hypertension, Diabetes etc)” [Diabetes & Metabolic Syndrome: Clinical Research & Reviews, 2020; 14 (3): 251–254] https://doi.org/10.1016/j.dsx.2020.03.012
• 7.“Effectiveness and safety of routine calcium supplementation in postmenopausal women. A narrative review” [Diabetes & Metabolic Syndrome: Clinical Research & Reviews, 2020; 14 (4): 435–442] https://doi.org/10.1016/j.dsx.2020.04.016
• 8.“Prevalence of type 2 diabetes mellitus (T2DM) in India: A systematic review (1994–2018)” [Diabetes & Metabolic Syndrome: Clinical Research & Reviews, 2020; 14 (5): 897–906] https://doi.org/10.1016/j.dsx.2020.05.040
• 9.“Pattern of liver function and clinical profile in COVID-19: A cross-sectional study of 91 patients” [Diabetes & Metabolic Syndrome: Clinical Research & Reviews, 2020; 14 (6): 1951–1954] https://doi.org/10.1016/j.dsx.2020.10.001
• 10.“Association of Meteorin-Like Hormone with insulin resistance and body composition in healthy Iranian adults” [Diabetes & Metabolic Syndrome: Clinical Research & Reviews, 2020; 14 (5): 881–885] https://doi.org/10.1016/j.dsx.2020.05.031
• 11.“Mechanism of inflammatory response in associated comorbidities in COVID-19” [Diabetes & Metabolic Syndrome: Clinical Research & Reviews, 2020; 14 (4): 597–600] https://doi.org/10.1016/j.dsx.2020.05.025
• 12.“Testosterone replacement therapy in men with type 2 diabetes mellitus and functional hypogonadism –an Integrated Diabetes and Endocrine Academy (IDEA) consensus guideline” [Diabetes & Metabolic Syndrome: Clinical Research & Reviews, 2021; 15 (4)] https://doi.org/10.1016/j.dsx.2021.102191
• 13.“Glycemic improvement with a novel interim intervention technique using retrospective professional continuous glucose monitoring (GLITTER study): A study from Mumbai, India” [Diabetes & Metabolic Syndrome: Clinical Research & Reviews, 2021; 15 (3): 703–709] https://doi.org/10.1016/j.dsx.2021.03.011
• 14.“The impact of COVID-19 on Diabetic Ketoacidosis patients” [Diabetes & Metabolic Syndrome: Clinical Research & Reviews, 2022; 16 (1)] https://doi.org/10.1016/j.dsx.2022.102389
• 15.“Application of tele-podiatry in diabetic foot management: A series of illustrative cases” [Diabetes & Metabolic Syndrome: Clinical Research & Reviews, 2020; 14 (6): 1991–1995] https://doi.org/10.1016/j.dsx.2020.10.009
• 16.“Lactobacillus rhamnosus GG and HbA1c in middle age and older adults without type 2 diabetes mellitus: A preliminary randomized study” [Diabetes & Metabolic Syndrome: Clinical Research & Reviews, 2020; 14 (5): 907–909] https://doi.org/10.1016/j.dsx.2020.05.034
• 17.“Comparative efficacy and safety of basal insulins: A review” [Diabetes & Metabolic Syndrome: Clinical Research & Reviews, 2021; 15 (6)] https://doi.org/10.1016/j.dsx.2021.102318